Publication | Closed Access
Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells.
58
Citations
30
References
2006
Year
XIAP is overexpressed in pancreatic cancer and contributes to chemoresistance. Interfering with this pathway may have potential therapeutic role in the treatment of this disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1